Inhibition of Hypoxia and EGFR Sensitizes TNBC to Cisplatin and Suppresses Bulk and Cancer Stem Cells

Sarah McGarry
uO Research (University of Ottawa)
November 26, 2020
10.20381/ruor-25730
Cited by 0

Related Papers

Dual inhibition of Wnt and Yes‐associated protein signaling retards the growth of triple‐negative breast cancer in both mesenchymal and epithelial states
|Molecular Oncology|2018|75
Co-inhibition of mTORC1, HDAC and ESR1α retards the growth of triple-negative breast cancer and suppresses cancer stem cells
|Cell Death and Disease|2018|46
Both bulk and cancer stem cell subpopulations in triple‐negative breast cancer are susceptible to Wnt, <scp>HDAC</scp>, and <scp>ER</scp>α coinhibition
|FEBS Letters|2016|30
PO-428 Therapeutic potential of nanoparticle encapsulated Wnt and YAP inhibitors using patient derived xenograft models for the treatment of triple negative breast cancer
|ESMO Open|2018|0